Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.72 |
| ▸ | RECQL | P46063 | 2/20 | 0.72 |
| ▸ | GLA | P06280 | 1/20 | 0.72 |
| ▸ | HPGD | P15428 | 1/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.72 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.72 |
| ▸ | BLM | P54132 | 1/20 | 0.72 |
| ▸ | CA1 | P00915 | 12/20 | 0.54 |
| ▸ | CA2 | P00918 | 12/20 | 0.54 |
| ▸ | CA9 | Q16790 | 9/20 | 0.46 |
| ▸ | CA12 | O43570 | 4/20 | 0.45 |
| ▸ | CA7 | P43166 | 4/20 | 0.45 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.45 |
| ▸ | CA3 | P07451 | 2/20 | 0.45 |
| ▸ | CA4 | P22748 | 2/20 | 0.45 |
| ▸ | CA6 | P23280 | 2/20 | 0.45 |
| ▸ | CA5A | P35218 | 2/20 | 0.45 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2634750 | 0.98 | — | — | |
| Fluoride SCHEMBL28262916 | 0.93 | TSHR (0.76) | TSHRRECQLGLAHPGDMAPK1 | |
| Potassium Ion SCHEMBL6534824 | 0.93 | TSHR (0.75) | TSHRRECQLGLAHPGDMAPK1 | |
| SCHEMBL17456497 | 0.93 | TSHR (0.75) | TSHRRECQLGLAHPGDMAPK1 | |
| Lithium Ion SCHEMBL17456624 | 0.93 | TSHR (0.75) | TSHRRECQLGLAHPGDMAPK1 | |
| SCHEMBL302087 | 0.93 | TSHR (0.83) | TSHRRECQLGLAHPGDMAPK1 | |
| Zinc Ion SCHEMBL31471926 | 0.93 | TSHR (0.75) | TSHRRECQLGLAHPGDMAPK1 | |
| Amylosulfuric Acid SCHEMBL1531835 | 0.91 | RECQL (0.87) | TSHRRECQLGLAHPGDMAPK1 | |
| SCHEMBL11046781 | 0.88 | RECQL (0.91) | TSHRRECQLGLAHPGDMAPK1 | |
| SCHEMBL11372853 | 0.88 | RECQL (0.91) | TSHRRECQLGLAHPGDMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 300 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230072265-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF 4-({(1 R)-2-[5-(2-FLUORO-3METHOXYPHENYL)-3-{[2-FLUORO-6-(TRIFLUORO METHYL) PHENYL]METHYL}-4-METHYL-2,6-DIOXO-3,6DIHYDROPYRIMIDIN-1(2 H)-YL]-1-PHENYLETHYL}AMINO)BUTANOIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2023-03-09 | — | — | US | claimed |
| WO-2022097115-A1 | AN IMPROVED PROCESS FOR PREPARATION OF PROHEXADIONE AND ITS CALCIUM SALT | HIKAL LIMITED (IN) | 2022-05-12 | — | — | WO | claimed |
| WO-2021130776-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF 4-({(1 R)-2-[5-(2-FLUORO-3METHOXYPHENYL)-3-{[2-FLUORO-6-(TRIFLUORO METHYL) PHENYL]METHYL}-4-METHYL-2,6-DIOXO-3,6DIHYDROPYRIMIDIN-1(2 H)-YL]-1-PHENYLETHYL}AMINO)BUTANOIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2021-07-01 | — | — | WO | claimed |
| WO-2021079380-A1 | IMPROVED PROCESS FOR THE PREPARATION OF (2S)-N-{(1S)-1-(2-CHLOROPHENYL)-2-[(3,3-DIFLUOROCYCLOBUTYL)-AMINO]-2-OXOETHYL}-1-(4-CYANOPYRIDIN-2-YL)-N-(5-FLUOROPYRIDIN-3-YL)-5-OXOPYRROLIDINE-2-CARBOXAMIDE | MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) | 2021-04-29 | — | — | WO | claimed |
| WO-2020044102-A1 | BROMINE FREE PREPARATION OF 5H-DIBENZO [A,D] CYCLOHEPTEN-5-ONE | R L FINE CHEM PRIVATE LIMITED (IN) | 2020-03-05 | — | — | WO | claimed |
| CN-110467567-A | A kind of preparation method of ZEN 90160 | CAC NANTONG CHEMICAL CO LTD | 2019-11-19 | — | — | CN | claimed |
| CN-109369708-A | A kind of green synthesis process of O, O- diethyl sulfo-phosphoryl chloride | 重庆华歌生物化学有限公司 | 2019-02-22 | — | — | CN | claimed |
| CN-105585525-B | A kind of synthetic method of Montelukast Sodium | 山东新时代药业有限公司 | 2018-08-14 | — | — | CN | claimed |
| CN-104803969-B | A kind of acrylic type contains thio sulfonate group high refractive index monomers and its synthetic method | 合肥工业大学 | 2017-12-19 | — | — | CN | claimed |
| US-20170291866-A1 | Production of Mixed Aldol Products from the Products of Hydroformylation Reactions | Texmark Chemicals, Inc. (US) | 2017-10-12 | — | — | US | claimed |
| WO-2008126106-A2 | NOVEL AND IMPROVED PROCESSES FOR THE PREPARATION OF INTERMEDIATES OF DARIFENACIN, DARIFENACIN AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | SATYANARAYANA REDDY MANNE (IN) | 2008-10-23 | — | — | WO | claimed |
| WO-2007148344-A2 | PROCESS FOR THE PREPARATION OF OLMESARTAN MEDOXOMIL | MATRIX LABORATORIES LIMITED (IN) | 2007-12-27 | — | — | WO | claimed |
| EP-1704134-B1 | A PROCESS FOR ISOLATING, PURIFYING AND FORMULATING A STABLE, COMMERCIAL GRADE LUTEIN PASTE FROM OLEORESIN | INDUS BIOTECH PVT LTD (IN) | 2007-11-07 | — | — | EP | claimed |
| WO-2007122638-A2 | AN IMPROVED PROCESS FOR PREPARATION OF LAMOTRIGINE INTERMEDIATES | RATNAMANI BIO-CHEMICALS & PHARMACEUTICALS PVT. LTD. (IN) | 2007-11-01 | — | — | WO | claimed |
| US-7179930-B2 | Process for isolating, purifying and formulating a stable, commercial grade Lutein paste from oleoresin | INDUS BIOTECH PRIVATE LIMITED (IN) | 2007-02-20 | — | — | US | claimed |
| US-20060252940-A1 | CRYSTALLINE 1-[2-(2,4-DIFLUOROPHENYL)-OXIRANYL METHYL]-1H-1,2,4-TRIAZOLE | DR. REDDY'S LABORATORIES, INC. | 2006-11-09 | — | — | US | claimed |
| EP-1704134-A1 | A PROCESS FOR ISOLATING, PURIFYING AND FORMULATING A STABLE, COMMERCIAL GRADE LUTEIN PASTE FROM OLEORESIN | Indus Biotech Pvt. Ltd. (IN) | 2006-09-27 | — | — | EP | claimed |
| WO-2006035459-A1 | AN IMPROVED PROCESS FOR THE PRODUCTION OF DERIVATIVES OF THIOZOLIDINEDIONES AND THEIR PRECURSORS | MOREPEN LABORATORIES LIMITED (IN) | 2006-04-06 | — | — | WO | claimed |
| US-20050182280-A1 | Process for isolating, purifying and formulating a stable, commercial grade Lutein paste from oleoresin | INDUS BIOTECH PVT. LTD. (IN) | 2005-08-18 | — | — | US | claimed |
| WO-2005068409-A1 | A PROCESS FOR ISOLATING, PURIFYING AND FORMULATING A STABLE, COMMERCIAL GRADE LUTEIN PASTE FROM OLEORESIN | INDUS BIOTECH PRIVATE LIMITED (IN) | 2005-07-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060252940-A1 | CRYSTALLINE 1-[2-(2,4-DIFLUOROPHENYL)-OXIRANYL METHYL]-1H-1,2,4-TRIAZOLE | CYP2F1, CYP4B1, CYP3A4 | TSHR 3316/4885RECQL 1564/4885GLA 1716/4885 |
| US-20050182280-A1 | Process for isolating, purifying and formulating a stable, commercial grade Lutein paste from oleoresin | LRAT, LIPC, LIPA | TSHR 2123/4885RECQL 419/4885GLA 871/4885 |
| US-20230072265-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF 4-({(1 R)-2-[5-(2-FLUORO-3METHOXYPHENYL)-3-{[2-FLUORO-6-(TRIFLUORO METHYL) PHENYL]METHYL}-4-METHYL-2,6-DIOXO-3,6DIHYDROPYRIMIDIN-1(2 H)-YL]-1-PHENYLETHYL}AMINO)BUTANOIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS | BPNT1, GABRA6, GABRA1 | TSHR 3072/4885RECQL 4402/4885GLA 3864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.